REFERENCES:
  1. Janson C, Johannessen A, Franklin K, Svanes C, Schiöler L, Malinovschi A, Gislason T, Benediktsdottir B, Schlünssen V, Jögi R, Jarvis D, Lindberg E. Change in the prevalence asthma, rhinitis and respiratory symptom over a 20 year period: associations to year of birth, life style and sleep rate symptoms. BMC Pulmonary Medicine. 2018;18:152.
  2. Barber D, Diaz-Perales A, Escribese MM, Kleine-Tebbe J, Matricardi PM, Ollert M, Santos AF, Sastre J. Molecular allergology and its impact in specific allergy diagnosis and therapy. Allergy. 2021;76:3642-3658.
  3. Pfaar O, Bachert C, Bufe A, Buhl R, Ebner C, Eng P et al. Guidelines on allergen-specific immunotherapy in IgE-mediated allergic diseases Allergo J Int 2014. 23(8):282-319.
  4. Sekerkova A, Polackova M, Striz I. Detection of Phl p 1, Phl p 5, Phl p 7 and Phl p 12 specific IgE antibodies in the sera of children and adult patients allergic to Phleum pollen. Allergol Int. 2012;61(2):339–46.
  5. Moingeon P, Floch VB-L, Airouche S, Baron-Bodo V, Nony E, Mascarell L. Allergen immunotherapy for birch pollen-allergic patients: recent advances. Immunotherapy. 2016;8(5):555–67.
  6. Imhof K, Probst E, Seifert B, Regenass S, Schmid-Grendelmeier P. Ash pollen allergy: reliable detection of sensitization on the basis of IgE to Ole e 1. Allergo J Int. 2014;23(3):78–83.
  7. Niederberger V, Purohit A, Oster JP, Spitzauer S, Valenta R, Pauli G. The allergen profile of ash (Fraxinus excelsior) pollen: cross-reactivity with allergens from various plant species. Clin. Exp. Allergy. 2002;32:933-941.
  8. https://www.pollenwarndienst.at/aktuelle-belastung/pollen-jahr.html; cited: 21-01-2022
  9. Lombardero M, García-Sellés FJ, Polo F, Jimeno L, Chamorro MJ, García-Casado G, et al. Prevalence of sensitization to Artemisia allergens Art v 1, Art v 3 and Art v 60 kDa. Cross-reactivity among Art v 3 and other relevant lipid-transfer protein allergens. Clin Exp Allergy 2004;34(9):1415–21.
  10. Gadermaier G, Wopfner N, Wallner M, Egger M, Didierlaurent A, Regl G, et al. Array-based profiling of ragweed and mugwort pollen allergens. Allergy. 2008;63(11):1543–9.
  11. Wopfner N, Gadermaier G, Egger M, Asero R, Ebner C, Jahn-Schmid B, et al. The spectrum of allergens in ragweed and mugwort pollen. Int. Arch. Allergy Immunol. 2005;138(4):337–46.
  12. Pichler U, Hauser M, Wolf M, Bernardi ML, Gadermaier et al. Pectate lyase pollen allergens: Sensitization profiles and cross-reactivity pattern. PloSOne 2015; 10: e 0120038
  13. Hartl C, Horak F. Significance of component-resolved diagnostics for diagnosis and therapy of patients with inhalant allergies. MedUni Wien ePub 2021; https://repositorium.meduniwien.ac.at/obvumwhs/content/titleinfo/6184303
  14. Sastre J, Landivar ME, Ruiz-Garcia M, Andregnette-Rosigno MV, Mahillo I. How molecular diagnosis can change allergen-specific immunotherapy prescription in a complex pollen area. Allergy 2012; 67: 709-711.
  15. Stringari G, Tripodi S, Caffarelli C, Dondi A, Asero R, Di Rienzo Businco A, et al. The effect of component-resolved diagnosis on specific immunotherapy prescription in children with hay fever. J Allergy Clin Immunol. 2014; 134(1): 75–81.
  16. San Nicoló M, Högerle C, Gellrich D, Gröger M. Relevance of Major Allergens in Weed Pollen Allergy. Int Arch Allergy Immunol 2021; 182: 637-641.
  17. Stemeseder T, Hemmer W, Hawranek T, Gadermaier G. Marker allergens of weed pollen – basic considerations and diagnostic benefits in the clinical routine. Part 16 of the Series Molecular Allergology. Allergo J Int 2014; 23: 174-280.